Is Xilio Therapeutics, Inc. (XLO) a Buy, Sell, or Hold?
NASDAQ : XLO
Xilio Therapeutics, Inc. — Competitors
$9.05 USD
-$0.13 (-1.42%)
- Volume
- 9.31K
- Average Volume
- 43.68K
- Market Capitalization
- $59.51M
- P/E Ratio
- -6.07
- Dividend Yield
- 0.00%
- Price Target
- $98.00
- Year High
- $12.74
- Year Low
- $6.47
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.25
XLO vs. The Competition
| Properties | XLO | ALGS | ATNM | FGEN |
|---|---|---|---|---|
| Market Cap | $59.51M | $43.32M | $26.01M | $36.69M |
| Shares Outstanding | $6.58M | $6.19M | $31.37M | $4.05M |
| P/E Ratio | -6.07 | -0.96 | 2.3 | 0.22 |
| EPS | -0.08 | -7.28 | 0.36 | 40.43 |
| Day Low | 8.7812 | 6.75 | 0.7945 | 9.02 |
| Day High | 9.05 | 7.41 | 0.829 | 9.21 |
| Year Low | 6.468 | 3.98 | 0.735 | 4.85 |
| Year High | 12.74 | 13.689 | 1.806 | 21.95 |
| Average Price 50 | 8.8093 | 5.4088 | 0.94956 | 9.1405 |
| Average Price 200 | 8.87412 | 7.23658 | 1.19267 | 8.83568 |
| Volume | 9307 | 186.62K | 240.41K | 29255 |
| Average Volume | - | - | - | - |